Fig. 2
From: Evidence-based sizing of non-inferiority trials using decision models
Quality-adjusted life-expectancy in low-risk adenoma patients for the current intervention and the alternative intervention at different levels of effectiveness. Current intervention is 5-yearly surveillance; Alternative intervention is 10-yearly surveillance. Different levels of effectiveness represent difference levels of CRC risk after the alternative intervention